Transgene Biotek Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
Depreciation, Depletion & Amortization
10,150.80
172,155.30
171,805.10
205,023.50
175,271.40
Other Funds
142,213.30
74,468.10
49,088.50
66,165.10
15,279.50
Funds from Operations
132,020.20
1,087,501.00
29,539.00
55,804.60
6,232.30
Changes in Working Capital
4,066.10
1,155,531.70
5,656.90
8,888.50
6,454.00
Net Operating Cash Flow
127,954.00
68,030.80
35,195.80
64,693.10
221.70
Capital Expenditures
930,704.40
74,542.80
45,733.90
64,700.10
-
Sale of Fixed Assets & Businesses
799,303.50
-
-
-
-
Net Investing Cash Flow
153,542.10
74,542.80
45,733.90
64,700.10
-
Issuance/Reduction of Debt, Net
4,576.60
94,025.00
10,322.30
-
-
Net Financing Cash Flow
26,157.70
5,975.00
10,322.30
-
-
Net Change in Cash
569.70
537.00
215.70
7.00
221.70
Free Cash Flow
802,750.40
68,030.80
35,195.80
64,693.10
221.70
Change in Capital Stock
21,581.20
100,000.00
-
-
-
Other Uses
22,141.10
-
-
-
-
About Transgene Biotek
View Profile
